“Abbott’s new Pandemic Defense Coalition is dedicated to the early detection of, and rapid response to, future pandemic threats,” says Bassem Bibi, the company’s VP for Rapid Diagnostics.
Abbott has developed and launched 12 tests to detect the SARS-CoV-2 virus and its antibodies and has so far delivered more than 1 billion tests globally. “Hospitals” magazine recently interviewed Mr. Bassem Bibi, Divisional Vice President for Abbott’s rapid diagnostic business in the Middle East & Africa who talked about Abbott’s rapid diagnostic tests and their role in detecting the virus.